UK based medical device company announces two new patents granted by the US Patent and Trademark Office
SIRAKOSS Ltd., a UK-based medical device company developing innovative bone grafting solutions for the $3 billion global orthopaedic market, has announced that the United States Patent and Trademark Office (USPTO) has granted two patents for its bone graft technologies. SIRAKOSS‘ patent portfolio encompasses advanced synthetic bone graft technologies which form the company’s product pipeline designed to address the significant clinical need for a fully-synthetic, standalone bone void filler. SIRAKOSS’ technologies provide consistently effective bone regeneration without the established risks found by using either autograft or therapeutics-based products such as BMP’s.
Source: Orthogate - Latest News - Category: Orthopaedics Tags: Featured Industry News Source Type: news